The invention relates to a nutraceutical and/or pharmaceutical composition intended to stimulate the production of beta-defensins-2. It comprises as sole active principle a gluco-oligosaccharide corresponding to the oligomeric base structure of formula (I) for the treatment of intestinal inflammations in an amount of 0.5 to 10 g. Application for the treatment of functional colopathy.